Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle

Naunyn Schmiedebergs Arch Pharmacol. 1979 Dec;310(2):129-38. doi: 10.1007/BF00500277.

Abstract

The effects of the four nitro-compounds nitroglycerin, nitroprusside-Na, NaNO2 and B 744-99 were studied simultaneously on length and on cGMP-levels in isolated circular strips of bovine coronary arteries. 1. All 4 nitro-compounds concentration dependently relaxed the strips in close association with pronounced increases in cGMP-levels which preceded the mechanical responses. 2. The relaxant effects of all 4 nitro-compounds were significantly potentiated by the predominant inhibitor of cGMP-hydrolysis M & B 22,948, which also potentiated the increase in cGMP-levels of the two nitro-compounds in which it was studied (nitroglycerin and nitroprusside-Na). 3. Non-substituted cGMP and -- much stronger -- its 8 bromo-derivative also relaxed the strips and these effects were likewise potentiated by M & B 22,948. 4. When the log increase in cGMP produced by the 4 nitro-compounds were plotted against percent relaxation (probit scale) a linear and highly significant positive correlation was obtained. 5. The results provide evidence that the increases in cGMP caused by the 4 nitro-compounds studied are responsible for the smooth muscle relaxing actions of these drugs.

MeSH terms

  • 3',5'-Cyclic-GMP Phosphodiesterases / metabolism
  • Animals
  • Cattle
  • Coronary Vessels / drug effects*
  • Cyclic GMP / analogs & derivatives
  • Cyclic GMP / pharmacology
  • Cyclic GMP / physiology*
  • In Vitro Techniques
  • Muscle Contraction / drug effects*
  • Muscle Relaxation / drug effects*
  • Muscle, Smooth, Vascular / drug effects*
  • Nitro Compounds / pharmacology*
  • Phosphodiesterase Inhibitors / pharmacology
  • Time Factors

Substances

  • Nitro Compounds
  • Phosphodiesterase Inhibitors
  • 3',5'-Cyclic-GMP Phosphodiesterases
  • Cyclic GMP